$4.34B
$1.2 Million
0.0% of portfolio
7,000
Q2 2024
Added 52.17%
$3.47B
$658,000
0.0% of portfolio
37,300
Q2 2024
Reduced 31.18%
$3.98B
$1.02 Million
0.0% of portfolio
11,830
Q3 2024
Added 14.52%
$2.64B
$286,000
0.0% of portfolio
2,800
Q3 2024
Reduced 95.39%
$4.58B
$1.11 Million
0.0% of portfolio
60,556
Q2 2023
Added 54.65%
$1.6B
$508,000
0.0% of portfolio
28,457
Q3 2024
Added 18.78%
$4.53B
$908,000
0.0% of portfolio
57,865
Q3 2024
Added 16.98%
$3.44B
$965,000
0.0% of portfolio
19,703
Q2 2024
Added 42.74%
Madison Square Garden Entmt Com Cl A
-
$323,000
0.0% of portfolio
-
Q3 2024
New
$4.52B
$723,000
0.0% of portfolio
3,472
Q3 2024
Added 20.89%
$2.23B
$325,000
0.0% of portfolio
23,500
Q2 2022
Added 6.82%
$3.2B
$765,000
0.0% of portfolio
10,400
Q2 2023
Added 48.57%
$2.64B
$1.15 Million
0.0% of portfolio
70,700
Q3 2024
Added 19.63%
$780M
$371,000
0.0% of portfolio
44,600
Q3 2024
Added 35.56%
$1.64B
$308,000
0.0% of portfolio
7,766
Q2 2024
Added 4.02%
$1.76B
$469,000
0.0% of portfolio
95,400
Q3 2024
Added 22.62%
$3.75B
$527,000
0.0% of portfolio
7,177
Q2 2023
Added 95.19%
$1.4B
$262,000
0.0% of portfolio
14,779
Q3 2023
Added 26.32%
Masterbrand Inc Common Stock
-
$603,000
0.0% of portfolio
-
Q3 2024
Added 14.04%
$2.33B
$466,000
0.0% of portfolio
4,166
Q3 2024
Added 10.62%
$5.71B
$813,000
0.0% of portfolio
5,700
Q2 2024
Reduced 5.0%
$1.41B
$291,000
0.0% of portfolio
20,081
Q2 2023
Added 60.89%
$4.29B
$1.26 Million
0.0% of portfolio
13,516
Q3 2024
Added 18.4%
$2.93B
$648,000
0.0% of portfolio
6,158
Q3 2024
Added 44.62%
$3.99B
$205,000
0.0% of portfolio
3,258
Q3 2024
New
$2.39B
$350,000
0.0% of portfolio
5,300
Q3 2024
Added 17.78%
$1.91B
$425,000
0.0% of portfolio
17,177
Q2 2024
Reduced 0.58%
$2.58B
$567,000
0.0% of portfolio
7,337
Q3 2024
Added 10.55%
$3.57B
$611,000
0.0% of portfolio
55,231
Q3 2024
Added 17.94%
$2.35B
$281,000
0.0% of portfolio
43,100
Q3 2024
Added 26.76%
$4.49B
$805,000
0.0% of portfolio
11,751
Q2 2021
Added 11.37%
$1.99B
$655,000
0.0% of portfolio
13,000
Q3 2024
Added 26.21%
$3.88B
$780,000
0.0% of portfolio
35,936
Q3 2024
Reduced 27.16%
$1.24B
$747,000
0.0% of portfolio
27,288
Q3 2024
Added 12.82%
$2.18B
$411,000
0.0% of portfolio
9,295
Q4 2022
Reduced 19.84%
$1.87B
$221,000
0.0% of portfolio
16,900
Q3 2024
New
$2.16B
$505,000
0.0% of portfolio
37,204
Q3 2024
Added 28.27%
$3.21B
$688,000
0.0% of portfolio
16,700
Q4 2023
Reduced 7.73%
$330M
$262,000
0.0% of portfolio
2,800
Q3 2024
Added 21.74%
$628M
$223,000
0.0% of portfolio
90,900
Q2 2024
Added 40.49%
$4.44B
$417,000
0.0% of portfolio
8,883
Q3 2024
Added 37.02%
$3.32B
$1.19 Million
0.0% of portfolio
14,151
Q3 2024
Added 9.27%
$3.93B
$1.11 Million
0.0% of portfolio
22,916
Q3 2024
Added 36.27%
$951M
$273,000
0.0% of portfolio
25,000
Q2 2024
Added 60.26%
$2.02B
$313,000
0.0% of portfolio
20,100
Q4 2022
Reduced 37.96%
$3.99B
$711,000
0.0% of portfolio
22,500
Q3 2024
Added 92.31%
$2.87B
$266,000
0.0% of portfolio
2,351
Q4 2022
New
$2.85B
$1.08 Million
0.0% of portfolio
64,264
Q3 2024
Added 11.45%
$2.32B
$372,000
0.0% of portfolio
25,200
Q3 2024
Added 12.0%
Neumora Therapeutics Inc. Com
-
$351,000
0.0% of portfolio
-
Q3 2024
Added 35.03%